Form 4: VolitionRX COO Gaetan Michel Receives Stock Award in Lieu of Cash Compensation

Gaetan Michel, Chief Operating Officer of VolitionRX Ltd, received 13,689 restricted stock units (RSUs) on June 1, 2024, in lieu of cash compensation.

Summary

• On June 1, 2024, VolitionRX Ltd's Chief Operating Officer, Gaetan Michel, was granted 13,689 restricted stock units (RSUs).
• These RSUs were awarded under the company's 2015 Stock Incentive Plan as a substitute for cash compensation.
• The RSUs vest in three equal installments of 4,563 units on June 1, 2024, July 1, 2024, and August 1, 2024.
• A further time-based vesting installment occurs on May 1, 2025, contingent upon continued service.
• Upon vesting and settlement, Michel will receive common stock shares equivalent to the number of vested RSUs.
• Following the transaction, Michel directly owns 354,199 shares of VolitionRX Ltd.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation. The stock award is a positive sign of aligning management with shareholder interests, but it's not a major event.

Positives

• The award of RSUs in lieu of cash compensation may preserve the company's cash reserves.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Stock awards are a common form of executive compensation in the biotechnology industry, often used to align management's interests with those of shareholders and to conserve cash.

Stakeholder Impact

• Shareholders may view the RSU grant as a way to align management's interests with the company's long-term performance.
• Employees may see this as a standard compensation practice for executives.

Key Dates